Insulin resistance in patients with a recent diagnosis of coronary artery disease

Journal of Hypertension

Volumn 14, Issue 12, 1996, Pages 1477-1482

  Piédrola, Gonzalo ^a   Novo, Enrique ^a   Serrano Gotarredona, Joaquín ^a   Escobar Morreale, Héctor F ^a   Villa, Eduardo ^a   De Dios Luna, Juan ^b   García Robles, Rafael ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Coronary artery disease; Dyslipidaemia; Hyperuricaemia; Insulin resistance

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY RISK; EARLY DIAGNOSIS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SUPPRESSION TEST; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 0030445831     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199612000-00015     Document Type: Article

References (35)

1. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991, 14:173-194.
2. Reaven GM: Banting lecture. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
3. Fontbonne AM, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, et al.: Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study. 15-year follow-up. Diabetologia 1991, 34:356-361.
4. Wellborn TA, Wearne K: Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979, 2:154-160.
5. Pyörälä K: Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results of two population studies in Finland. Diabetes Care 1979, 2:131-141.
6. Desprès JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, et al: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996, 334:952-957.
7. Hillson RM, Hockaday TDR, Man JI, Newton DJ: Hyperinsulinemia is associated with development of electrocardiographic abnormalities in diabetics. Diabetes Res 1984, 1:143-149.
8. Bergstrom RW, Leonetti DL, Newell-Morris LL, Shuman WP, Wahl PW, Fujimoto WY: Association of plasma triglyceride and C-peptide with coronary heart disease in Japanese-American men with a high prevalence of glucose intolerance. Diabetologia 1990, 33:489-496
9. Hamsten A, Efendic S, Walldius G, Szamosi A, De Faire U: Glucose tolerance and insulin response to glucose in non diabetic young male survivors of myocardial infarction. Am Heart J 1987, 113:917-927.
10. Hughes LO, Cruickshank JK, Wright J, Raftery ER: Disturbances of insulin in British Asian and white men surviving myocardial infarction. BMJ 1989, 299:537-541.
11. O'Brien T, Young WF, Palumbo PJ, O'Brien P: Hypertension and dyslipidemia in patients with insulinoma. Mayo Clin Proc 1993, 68:141-146.
12. Sawicki PT, Heinemann L, Starke A, Berger M: Hyperinsulinemia is not linked with blood pressure elevation in patients with insulinoma. Diabetologia 1992, 35:649-652.
13. Zimmermann S, Philips RA, Dunaif A, Finegood DT, Wilkenfeld C, Ardeljan M, et al.: Polycystic ovarian syndrome: lack of hypertension despite profound insulin resistance. J Clin Endocrinol Metab 1992, 75:508-513.
14. Conway GS, Agrawal R, Betteridge DJ, Jacobs HS: Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol 1992, 37:119-125.
15. WHO Study Group. Definition, Diagnosis and Classification: Diabetes Mellitus. Geneva: World Health Organization; 1985:9-25.
16. Shen D-C, Shieh S-M, Fuh MM, Wu DA, Chen YD, Reaven GM: Resistance to insulin-stimulated glucose uptake in patients with hypertension. J Clin Endocrinol Metab 1988, 68:580-586.
17. Maheux P, Jeppesen J, Sheu WHH, Hollenbeck CB, Clinkbeard C, Greenfield MS, et al.: Additive effects of obesity, hypertension, and type 2 diabetes on insulin resistance. Hypertension 1994, 24:695-698.
18. Friedwald WT, Levy R, Fredrickson DS: Estimation of serum low density lipoprotein without the use of a preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
19. Dean JD, Jones CJH, Hutchison SJ, Peters JR, Henderson AH: Hyperinsulinemia and microvascular angina ('syndrome X') Lancet 1991, 337:454-457.
20. Botker HE, Moller N, Ovesen P, Mengel A, Schmitz O, Orskov H, et al.: Insulin resistance in microvascular angina. Lancet 1993, 342:136-140.
21. Shinozaki K, Suzuki M, Ikebuchi M, Takaki H, Hara Y, Tsushima M, et al.: Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina. Circulation 1995, 92:1749-1757.
22. Martinez FJ, Villa E, Serrano J, Garcia-Robles R: Diagnosis of insulin resistance. Drugs 1993, 46 (suppl 2):165-171.
23. Shen SW, Reaven GM, Farquhar JW: Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest 1970, 49:2151-2160.
24. Bergman RN, Finegood DT, Ader M: Assessment of insulin sensitivity in vivo. Endocrinol Rev 1985, 6:45-86.
25. Hauner H, Bogner E, Blum A: Body fat distribution and its association with metabolic and hormonal risk factors in women with angiographically assessed coronary artery disease. Evidence for the presence of a metabolic syndrome. Atherosclerosis 1994; 105:209-216.
26. Waters DD, Halphen C, Theroux P, David PR, Mizgala HF: Coronary artery disease in young women: clinical and angiographic features and correlation with risk factors. Am J Cardiol 1978, 42:41-47
27. Sewdarsen M, Vythilingum S, Jialal I: Abnormal glucose tolerance is the dominant risk factor in South African Indian women with myocardial infarction. Cardiology 1988; 75:381-386.
28. Tomono S, Kato N, Utsigi T, Ohno T, Shimizu M, Fukuda M, et al.: The role of insulin in coronary atherosclerosis. Diabetes Res Clin Pract 1994, 22:117-122.
29. Stout FW: Insulin and atheroma. An update. Lancet 1987, i:1077-1079.
30. Zimlichman R, Zeidel L, Gefel D, Eliahou H, Matas Z, Rosen B, et al.: Insulin induces medial hypertrophy of myocardial arterioles in rats. Am J Hypertens 1995, 8:915-950.
31. Stout RW: Insulin as a mitogenic factor: role in the pathogenesis of cardiovascular disease. Am J Med 1991, 90 (suppl 2A):S62-S65.
32. Nestler JE, Clore JN, Blackard WG: Dehydroepiandrosterone: the 'missing link' between hyperinsulinemia and atherosclerosis? FASEB J 1992, 6:3073-3075.
33. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, et al.: Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 1989, 320:702-706.
34. DeFronzo RA: Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web. J Cardiovasc Pharmacol 1992, 20 (suppl 11):S1-S16
35. Vuorinen-Markkola H, Yki-Järvinen H: Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994, 78:25-29.